| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Atrophy | 28 | 2019 | 335 | 4.370 |
Why?
|
| Muscle, Skeletal | 54 | 2023 | 4968 | 3.480 |
Why?
|
| Muscle Proteins | 28 | 2019 | 1160 | 2.190 |
Why?
|
| Growth Differentiation Factors | 5 | 2019 | 99 | 2.150 |
Why?
|
| Ubiquitin-Protein Ligases | 20 | 2019 | 1900 | 1.670 |
Why?
|
| Sarcopenia | 6 | 2023 | 378 | 1.610 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2019 | 845 | 1.570 |
Why?
|
| Myoblasts | 10 | 2019 | 234 | 1.490 |
Why?
|
| Muscle Fibers, Skeletal | 13 | 2018 | 553 | 1.440 |
Why?
|
| Cachexia | 9 | 2018 | 202 | 1.420 |
Why?
|
| Hypertrophy | 13 | 2019 | 562 | 1.390 |
Why?
|
| Activins | 6 | 2021 | 211 | 1.300 |
Why?
|
| Signal Transduction | 53 | 2021 | 23618 | 1.260 |
Why?
|
| Insulin-Like Growth Factor I | 17 | 2018 | 1934 | 1.130 |
Why?
|
| Muscle Development | 6 | 2017 | 258 | 1.070 |
Why?
|
| HMGA2 Protein | 3 | 2015 | 101 | 0.930 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 11 | 2014 | 174 | 0.870 |
Why?
|
| Receptors, Cholinergic | 10 | 2016 | 243 | 0.860 |
Why?
|
| Myoblasts, Skeletal | 3 | 2013 | 74 | 0.840 |
Why?
|
| Activin Receptors, Type II | 5 | 2019 | 122 | 0.840 |
Why?
|
| Neuromuscular Junction | 9 | 2016 | 399 | 0.820 |
Why?
|
| Follistatin-Related Proteins | 2 | 2021 | 48 | 0.810 |
Why?
|
| RNA-Binding Proteins | 4 | 2015 | 1885 | 0.780 |
Why?
|
| Diaphragm | 1 | 2023 | 357 | 0.760 |
Why?
|
| Agrin | 15 | 2002 | 75 | 0.730 |
Why?
|
| Myostatin | 7 | 2019 | 129 | 0.710 |
Why?
|
| Longevity | 4 | 2021 | 1083 | 0.680 |
Why?
|
| Aging | 11 | 2021 | 8728 | 0.670 |
Why?
|
| Hypogravity | 1 | 2019 | 3 | 0.670 |
Why?
|
| MyoD Protein | 3 | 2017 | 143 | 0.670 |
Why?
|
| Epidemics | 1 | 2024 | 516 | 0.600 |
Why?
|
| Manuscripts as Topic | 1 | 2017 | 15 | 0.590 |
Why?
|
| Glucuronidase | 1 | 2019 | 205 | 0.590 |
Why?
|
| Antibodies, Blocking | 3 | 2017 | 250 | 0.590 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2018 | 2060 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2022 | 2456 | 0.580 |
Why?
|
| Animals | 104 | 2024 | 168939 | 0.580 |
Why?
|
| Laboratory Personnel | 1 | 2016 | 19 | 0.550 |
Why?
|
| Science | 2 | 2010 | 234 | 0.540 |
Why?
|
| Space Flight | 1 | 2019 | 219 | 0.530 |
Why?
|
| Regeneration | 5 | 2017 | 1520 | 0.530 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2018 | 198 | 0.520 |
Why?
|
| Protein Kinases | 5 | 2009 | 1610 | 0.520 |
Why?
|
| Mice | 72 | 2024 | 81898 | 0.520 |
Why?
|
| Heart | 8 | 2019 | 4425 | 0.510 |
Why?
|
| Cell Line | 25 | 2021 | 15564 | 0.510 |
Why?
|
| Fibroblast Growth Factors | 3 | 2019 | 871 | 0.500 |
Why?
|
| Myosin Heavy Chains | 3 | 2019 | 403 | 0.480 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2010 | 2882 | 0.480 |
Why?
|
| Satellite Cells, Skeletal Muscle | 5 | 2017 | 124 | 0.470 |
Why?
|
| Escherichia coli Proteins | 4 | 2021 | 1055 | 0.440 |
Why?
|
| Ubiquitination | 4 | 2015 | 1007 | 0.430 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 14 | 1999 | 1621 | 0.430 |
Why?
|
| Musculoskeletal System | 1 | 2015 | 187 | 0.420 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 102 | 0.420 |
Why?
|
| Osteogenesis | 1 | 2019 | 1282 | 0.400 |
Why?
|
| Cell Differentiation | 17 | 2019 | 11657 | 0.400 |
Why?
|
| Apolipoproteins E | 3 | 2019 | 1459 | 0.400 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2013 | 99 | 0.400 |
Why?
|
| Research Personnel | 1 | 2016 | 589 | 0.390 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2012 | 68 | 0.380 |
Why?
|
| Dystrophin-Associated Proteins | 2 | 2016 | 60 | 0.380 |
Why?
|
| Cardiomegaly | 6 | 2014 | 591 | 0.380 |
Why?
|
| Rats | 27 | 2023 | 23717 | 0.380 |
Why?
|
| DNA Polymerase III | 2 | 2021 | 52 | 0.370 |
Why?
|
| Biological Phenomena | 1 | 2010 | 27 | 0.360 |
Why?
|
| Mice, Knockout | 24 | 2019 | 14473 | 0.350 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.350 |
Why?
|
| Publishing | 1 | 2017 | 837 | 0.350 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 792 | 0.350 |
Why?
|
| Organ Size | 7 | 2019 | 2262 | 0.340 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2004 | 4523 | 0.340 |
Why?
|
| Bone and Bones | 2 | 2019 | 2559 | 0.340 |
Why?
|
| Philosophy | 1 | 2010 | 69 | 0.340 |
Why?
|
| DNA Replication | 4 | 2021 | 1426 | 0.340 |
Why?
|
| F-Box Proteins | 1 | 2011 | 199 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 20 | 2024 | 22351 | 0.330 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 525 | 0.330 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2011 | 558 | 0.330 |
Why?
|
| Up-Regulation | 8 | 2018 | 4143 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2023 | 8108 | 0.320 |
Why?
|
| Muscular Diseases | 2 | 2011 | 551 | 0.320 |
Why?
|
| Muscular Dystrophies | 2 | 2011 | 393 | 0.310 |
Why?
|
| RNA Interference | 7 | 2019 | 2829 | 0.310 |
Why?
|
| Cell Size | 2 | 2017 | 625 | 0.310 |
Why?
|
| Dexamethasone | 5 | 2012 | 1962 | 0.310 |
Why?
|
| Orchiectomy | 1 | 2010 | 466 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 2902 | 0.300 |
Why?
|
| Gene Expression | 10 | 2019 | 7585 | 0.300 |
Why?
|
| Zebrafish | 1 | 2019 | 3035 | 0.290 |
Why?
|
| Histone Deacetylases | 3 | 2019 | 712 | 0.290 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2019 | 216 | 0.290 |
Why?
|
| Nerve Growth Factors | 11 | 1996 | 564 | 0.290 |
Why?
|
| Down-Regulation | 4 | 2019 | 2931 | 0.290 |
Why?
|
| DNA, Bacterial | 3 | 2021 | 1477 | 0.280 |
Why?
|
| Phosphorylation | 21 | 2024 | 8310 | 0.280 |
Why?
|
| BRCA1 Protein | 2 | 2023 | 1155 | 0.280 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 2 | 2017 | 21 | 0.270 |
Why?
|
| Gene Expression Regulation | 13 | 2019 | 11924 | 0.270 |
Why?
|
| Kidney | 2 | 2019 | 7073 | 0.260 |
Why?
|
| Running | 1 | 2010 | 488 | 0.260 |
Why?
|
| Myocardium | 6 | 2019 | 4765 | 0.250 |
Why?
|
| Obesity | 3 | 2024 | 13090 | 0.250 |
Why?
|
| Research Design | 4 | 2017 | 6206 | 0.250 |
Why?
|
| Dystrophin | 2 | 2005 | 283 | 0.240 |
Why?
|
| Smad3 Protein | 4 | 2014 | 166 | 0.240 |
Why?
|
| Muscle Denervation | 3 | 2019 | 60 | 0.240 |
Why?
|
| Ubiquitin | 5 | 2022 | 841 | 0.230 |
Why?
|
| Escherichia coli | 3 | 2021 | 4211 | 0.230 |
Why?
|
| Proteome | 2 | 2022 | 1894 | 0.230 |
Why?
|
| Interphase | 1 | 2024 | 226 | 0.220 |
Why?
|
| Terfenadine | 1 | 2003 | 15 | 0.220 |
Why?
|
| Loratadine | 1 | 2003 | 14 | 0.220 |
Why?
|
| Receptors, Nerve Growth Factor | 8 | 1999 | 199 | 0.220 |
Why?
|
| Cells, Cultured | 18 | 2021 | 18986 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 4 | 2017 | 9244 | 0.220 |
Why?
|
| Smad2 Protein | 3 | 2014 | 144 | 0.220 |
Why?
|
| Protein Binding | 13 | 2024 | 9326 | 0.210 |
Why?
|
| Biomedical Research | 2 | 2020 | 3459 | 0.210 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 100 | 0.210 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 101 | 0.210 |
Why?
|
| Enzyme Activation | 8 | 2018 | 3587 | 0.210 |
Why?
|
| Atrophy | 5 | 2013 | 1631 | 0.210 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 415 | 0.210 |
Why?
|
| Hindlimb Suspension | 2 | 2019 | 77 | 0.210 |
Why?
|
| Drug Monitoring | 1 | 2008 | 962 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2022 | 1319 | 0.200 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 492 | 0.200 |
Why?
|
| Protein Phosphatase 2 | 1 | 2024 | 231 | 0.200 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9528 | 0.200 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 3427 | 0.190 |
Why?
|
| Amino Acid Motifs | 1 | 2024 | 928 | 0.190 |
Why?
|
| Humans | 79 | 2024 | 766812 | 0.190 |
Why?
|
| Peptide Synthases | 1 | 2001 | 81 | 0.190 |
Why?
|
| Mitochondria | 3 | 2017 | 3678 | 0.180 |
Why?
|
| tau Proteins | 1 | 2011 | 2106 | 0.180 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5795 | 0.180 |
Why?
|
| Myocytes, Cardiac | 6 | 2019 | 1672 | 0.180 |
Why?
|
| Immunity | 2 | 2018 | 1002 | 0.180 |
Why?
|
| Motor Activity | 1 | 2010 | 2711 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2004 | 1168 | 0.180 |
Why?
|
| Genes, BRCA2 | 1 | 2023 | 591 | 0.180 |
Why?
|
| Cell Proliferation | 6 | 2024 | 10451 | 0.180 |
Why?
|
| Muscle Strength | 2 | 2017 | 639 | 0.170 |
Why?
|
| Receptors, Nicotinic | 3 | 1999 | 494 | 0.170 |
Why?
|
| History, 20th Century | 3 | 2016 | 2764 | 0.170 |
Why?
|
| HEK293 Cells | 6 | 2024 | 4277 | 0.170 |
Why?
|
| Neoplasms | 7 | 2019 | 22350 | 0.170 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2019 | 48 | 0.170 |
Why?
|
| Testosterone | 1 | 2010 | 2495 | 0.170 |
Why?
|
| History, 16th Century | 2 | 2010 | 70 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 4570 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20146 | 0.160 |
Why?
|
| History, 17th Century | 2 | 2010 | 108 | 0.160 |
Why?
|
| Azacitidine | 1 | 2021 | 337 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 205 | 0.160 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2018 | 4 | 0.160 |
Why?
|
| Double-Blind Method | 6 | 2022 | 12430 | 0.160 |
Why?
|
| Male | 38 | 2023 | 364154 | 0.160 |
Why?
|
| History, 18th Century | 2 | 2010 | 206 | 0.160 |
Why?
|
| Biotechnology | 2 | 1991 | 283 | 0.160 |
Why?
|
| Erythromycin | 1 | 1999 | 114 | 0.160 |
Why?
|
| Microarray Analysis | 2 | 2012 | 751 | 0.160 |
Why?
|
| Liver | 4 | 2024 | 7571 | 0.150 |
Why?
|
| South Africa | 1 | 2024 | 1873 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 996 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2012 | 5022 | 0.150 |
Why?
|
| Cricetinae | 2 | 2021 | 2416 | 0.150 |
Why?
|
| Alzheimer Disease | 5 | 2019 | 8715 | 0.150 |
Why?
|
| Neoplasms, Experimental | 1 | 2023 | 1228 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 1995 | 2426 | 0.150 |
Why?
|
| Benzothiazoles | 1 | 2019 | 244 | 0.150 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2018 | 49 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2013 | 7869 | 0.150 |
Why?
|
| DNA Repair | 3 | 2023 | 2050 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2016 | 1574 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 1627 | 0.140 |
Why?
|
| HIV Infections | 1 | 2024 | 17532 | 0.140 |
Why?
|
| Adult Stem Cells | 1 | 2019 | 221 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2005 | 414 | 0.140 |
Why?
|
| Isotretinoin | 1 | 1999 | 135 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1752 | 0.140 |
Why?
|
| Metallothionein | 1 | 2017 | 62 | 0.140 |
Why?
|
| Dietary Fats | 1 | 2005 | 2001 | 0.140 |
Why?
|
| Transcription Factors | 7 | 2014 | 12159 | 0.140 |
Why?
|
| Prediabetic State | 1 | 2022 | 547 | 0.140 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2017 | 193 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2020 | 566 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 804 | 0.130 |
Why?
|
| Research Report | 1 | 2019 | 367 | 0.130 |
Why?
|
| Calcineurin | 4 | 2014 | 235 | 0.130 |
Why?
|
| alpha Catenin | 1 | 2016 | 37 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2021 | 854 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 9613 | 0.130 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2016 | 101 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 9 | 1998 | 4401 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 304 | 0.130 |
Why?
|
| Cell Separation | 1 | 2021 | 1718 | 0.130 |
Why?
|
| Mutation | 10 | 2023 | 30214 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 482 | 0.130 |
Why?
|
| Transfection | 9 | 2011 | 5755 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 840 | 0.120 |
Why?
|
| Calcium | 1 | 2008 | 5783 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2021 | 1194 | 0.120 |
Why?
|
| Autophagy | 3 | 2019 | 1345 | 0.120 |
Why?
|
| Citric Acid | 1 | 2015 | 124 | 0.120 |
Why?
|
| Wasting Syndrome | 2 | 2017 | 96 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 1244 | 0.120 |
Why?
|
| NF-kappa B | 3 | 2011 | 2493 | 0.120 |
Why?
|
| Animals, Genetically Modified | 1 | 2019 | 1562 | 0.120 |
Why?
|
| Peer Review, Research | 1 | 2017 | 343 | 0.120 |
Why?
|
| DNA Damage | 2 | 2021 | 2469 | 0.110 |
Why?
|
| Glucocorticoids | 4 | 2017 | 2158 | 0.110 |
Why?
|
| Safety | 1 | 2019 | 1157 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 171 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2013 | 34 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2015 | 177 | 0.110 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2015 | 199 | 0.110 |
Why?
|
| Creatine Kinase | 2 | 2009 | 684 | 0.110 |
Why?
|
| Phenotype | 9 | 2014 | 16722 | 0.110 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 1137 | 0.110 |
Why?
|
| Acne Vulgaris | 1 | 1999 | 352 | 0.110 |
Why?
|
| Body Weight | 5 | 2017 | 4626 | 0.110 |
Why?
|
| Myositis, Inclusion Body | 1 | 2014 | 145 | 0.100 |
Why?
|
| Enzyme Inhibitors | 4 | 2018 | 3723 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 694 | 0.100 |
Why?
|
| Agriculture | 2 | 1991 | 186 | 0.100 |
Why?
|
| Quinolines | 1 | 2018 | 769 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2012 | 119 | 0.100 |
Why?
|
| Homeostasis | 2 | 2019 | 3343 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1791 | 0.100 |
Why?
|
| Imidazoles | 1 | 2018 | 1168 | 0.100 |
Why?
|
| Energy Metabolism | 3 | 2012 | 2903 | 0.100 |
Why?
|
| Sp1 Transcription Factor | 1 | 2012 | 143 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2015 | 2875 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2017 | 2626 | 0.100 |
Why?
|
| Trans-Activators | 1 | 2001 | 2856 | 0.100 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 18329 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2011 | 44 | 0.100 |
Why?
|
| Receptors, Growth Factor | 3 | 1999 | 324 | 0.100 |
Why?
|
| Mice, Transgenic | 10 | 2014 | 9546 | 0.090 |
Why?
|
| Starvation | 1 | 2012 | 141 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2019 | 839 | 0.090 |
Why?
|
| Templates, Genetic | 1 | 2011 | 188 | 0.090 |
Why?
|
| Cell Enlargement | 1 | 2011 | 58 | 0.090 |
Why?
|
| Lipolysis | 1 | 2012 | 211 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 1600 | 0.090 |
Why?
|
| Myogenin | 2 | 2001 | 54 | 0.090 |
Why?
|
| Physical Conditioning, Animal | 1 | 2014 | 363 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 3485 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 102 | 0.090 |
Why?
|
| Immunologic Factors | 2 | 2022 | 1594 | 0.090 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2014 | 260 | 0.090 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2010 | 139 | 0.090 |
Why?
|
| Protein Isoforms | 3 | 2019 | 1716 | 0.090 |
Why?
|
| Abelson murine leukemia virus | 1 | 1990 | 41 | 0.090 |
Why?
|
| Gene Deletion | 4 | 2005 | 2669 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 385 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4853 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 1998 | 936 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2016 | 950 | 0.090 |
Why?
|
| Tumor Necrosis Factors | 1 | 2010 | 109 | 0.090 |
Why?
|
| Ubiquitins | 1 | 2011 | 365 | 0.090 |
Why?
|
| Female | 26 | 2023 | 396532 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2018 | 872 | 0.080 |
Why?
|
| Trypanosoma brucei brucei | 2 | 1986 | 43 | 0.080 |
Why?
|
| Leukemia Virus, Murine | 1 | 1990 | 95 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 520 | 0.080 |
Why?
|
| Receptor Aggregation | 3 | 1997 | 72 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2012 | 370 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 432 | 0.080 |
Why?
|
| Denervation | 3 | 2009 | 265 | 0.080 |
Why?
|
| Placebos | 2 | 2014 | 1659 | 0.080 |
Why?
|
| Dioxoles | 1 | 2009 | 96 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2014 | 5690 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2429 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 1874 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 143 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 10745 | 0.080 |
Why?
|
| Activin Receptors, Type I | 1 | 2009 | 133 | 0.080 |
Why?
|
| Sirolimus | 2 | 2014 | 1540 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15912 | 0.080 |
Why?
|
| Complement System Proteins | 4 | 2022 | 738 | 0.080 |
Why?
|
| Cell Survival | 5 | 2013 | 5749 | 0.080 |
Why?
|
| Membrane Glycoproteins | 5 | 1998 | 3702 | 0.080 |
Why?
|
| Survival Rate | 2 | 2021 | 12826 | 0.080 |
Why?
|
| Transcription, Genetic | 7 | 2017 | 7612 | 0.080 |
Why?
|
| Proteins | 3 | 2012 | 6002 | 0.080 |
Why?
|
| Follistatin | 1 | 2009 | 138 | 0.080 |
Why?
|
| Heart Diseases | 3 | 2011 | 2817 | 0.080 |
Why?
|
| Arginine | 1 | 2012 | 932 | 0.070 |
Why?
|
| Osteocalcin | 1 | 2008 | 271 | 0.070 |
Why?
|
| Serine | 1 | 2012 | 828 | 0.070 |
Why?
|
| Physical Endurance | 1 | 2010 | 369 | 0.070 |
Why?
|
| 3T3 Cells | 9 | 1996 | 1082 | 0.070 |
Why?
|
| Leupeptins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Oncogene Proteins | 2 | 2006 | 715 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 800 | 0.070 |
Why?
|
| History, 19th Century | 1 | 2010 | 714 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2694 | 0.070 |
Why?
|
| Proteomics | 3 | 2021 | 3915 | 0.070 |
Why?
|
| Body Composition | 2 | 2022 | 2441 | 0.070 |
Why?
|
| Thermogenesis | 1 | 2012 | 495 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2010 | 588 | 0.070 |
Why?
|
| Phosphorus | 1 | 2008 | 336 | 0.070 |
Why?
|
| Genes | 3 | 1986 | 1824 | 0.070 |
Why?
|
| Histones | 1 | 2017 | 2595 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 872 | 0.070 |
Why?
|
| Carrier Proteins | 4 | 2009 | 4926 | 0.070 |
Why?
|
| Models, Biological | 6 | 2012 | 9464 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 7 | 1996 | 606 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2007 | 175 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1244 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 1211 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2007 | 3738 | 0.070 |
Why?
|
| Aged | 16 | 2022 | 171344 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2011 | 791 | 0.070 |
Why?
|
| Neurotrophin 3 | 7 | 1995 | 61 | 0.070 |
Why?
|
| Plasmids | 4 | 2020 | 2268 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 3833 | 0.070 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 776 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 2093 | 0.070 |
Why?
|
| Fibrosis | 2 | 2024 | 2078 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2006 | 197 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2662 | 0.060 |
Why?
|
| Acetylation | 2 | 2019 | 1055 | 0.060 |
Why?
|
| Myosins | 1 | 2007 | 407 | 0.060 |
Why?
|
| Hepatocytes | 2 | 2024 | 1246 | 0.060 |
Why?
|
| Inflammation | 3 | 2024 | 10863 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 2001 | 4168 | 0.060 |
Why?
|
| Oncogenes | 2 | 1993 | 1232 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2007 | 724 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2001 | 203 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2007 | 1525 | 0.060 |
Why?
|
| Amino Acid Sequence | 10 | 2002 | 13411 | 0.060 |
Why?
|
| Occupational Health | 1 | 1991 | 812 | 0.060 |
Why?
|
| Glucose | 2 | 2007 | 4340 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2306 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3759 | 0.060 |
Why?
|
| Eating | 1 | 2010 | 1539 | 0.060 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2003 | 16 | 0.060 |
Why?
|
| Complement C2 | 3 | 1981 | 45 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7475 | 0.050 |
Why?
|
| Receptors, Cell Surface | 4 | 1996 | 2815 | 0.050 |
Why?
|
| Benzamides | 1 | 2009 | 1375 | 0.050 |
Why?
|
| Insulin | 3 | 2007 | 6608 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 434 | 0.050 |
Why?
|
| Creatinine | 1 | 2008 | 1917 | 0.050 |
Why?
|
| Motor Endplate | 2 | 2019 | 20 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 1986 | 792 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2006 | 562 | 0.050 |
Why?
|
| Adult | 13 | 2022 | 223305 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2005 | 2275 | 0.050 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 59548 | 0.050 |
Why?
|
| Linear Models | 1 | 2012 | 5873 | 0.050 |
Why?
|
| Exons | 2 | 2005 | 2392 | 0.050 |
Why?
|
| Amino Acids | 1 | 2008 | 1711 | 0.050 |
Why?
|
| Synaptic Membranes | 2 | 1999 | 88 | 0.050 |
Why?
|
| Molecular Sequence Data | 10 | 2002 | 17609 | 0.050 |
Why?
|
| Autoantigens | 1 | 2006 | 890 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1996 | 0.050 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2001 | 11 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2001 | 40 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2007 | 1195 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 1791 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2010 | 1838 | 0.050 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2001 | 27 | 0.050 |
Why?
|
| Constriction, Pathologic | 2 | 2019 | 1104 | 0.050 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 4 | 1996 | 36 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 11062 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10816 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2001 | 83 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12808 | 0.050 |
Why?
|
| Drug Discovery | 2 | 2020 | 1065 | 0.050 |
Why?
|
| RNA | 2 | 2010 | 2715 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 330 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2004 | 1647 | 0.050 |
Why?
|
| Middle Aged | 13 | 2022 | 223267 | 0.050 |
Why?
|
| Escherichia coli K12 | 1 | 2021 | 35 | 0.050 |
Why?
|
| Iritis | 1 | 1980 | 15 | 0.050 |
Why?
|
| HLA Antigens | 4 | 1981 | 1339 | 0.050 |
Why?
|
| RNA, Messenger | 5 | 2004 | 12795 | 0.040 |
Why?
|
| NFATC Transcription Factors | 2 | 2014 | 393 | 0.040 |
Why?
|
| Complement Activation | 1 | 2022 | 447 | 0.040 |
Why?
|
| Stem Cells | 1 | 2013 | 3536 | 0.040 |
Why?
|
| Immobilization | 1 | 2001 | 227 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2008 | 4019 | 0.040 |
Why?
|
| Vitamins | 1 | 2008 | 1631 | 0.040 |
Why?
|
| Muscles | 2 | 2022 | 1576 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2018 | 65286 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3306 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 967 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1990 | 2841 | 0.040 |
Why?
|
| Replication Origin | 1 | 2020 | 77 | 0.040 |
Why?
|
| Laminin | 2 | 2000 | 404 | 0.040 |
Why?
|
| Neurons | 6 | 2002 | 9515 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 2 | 1980 | 340 | 0.040 |
Why?
|
| Ligands | 4 | 2019 | 3274 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2001 | 1688 | 0.040 |
Why?
|
| Time Factors | 4 | 2007 | 40149 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 1965 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 2470 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 376 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12246 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1969 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 131 | 0.040 |
Why?
|
| Fibroblasts | 6 | 2002 | 4166 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2008 | 2694 | 0.040 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 109 | 0.040 |
Why?
|
| Cardiotoxins | 1 | 2017 | 36 | 0.040 |
Why?
|
| Receptors, Mitogen | 1 | 1997 | 61 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2020 | 314 | 0.040 |
Why?
|
| Genotype | 3 | 2021 | 13036 | 0.040 |
Why?
|
| Gels | 1 | 1999 | 420 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 309 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2629 | 0.040 |
Why?
|
| Tyrosine | 3 | 1997 | 1425 | 0.040 |
Why?
|
| Cyclins | 1 | 1999 | 605 | 0.040 |
Why?
|
| Biomimetics | 1 | 2018 | 168 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 736 | 0.030 |
Why?
|
| Cricetulus | 1 | 2019 | 810 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2021 | 716 | 0.030 |
Why?
|
| Heart Failure | 2 | 2019 | 11879 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2017 | 6507 | 0.030 |
Why?
|
| Fluorescence | 1 | 2019 | 751 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15652 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2018 | 345 | 0.030 |
Why?
|
| Systole | 1 | 2019 | 935 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1867 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 712 | 0.030 |
Why?
|
| Flavonoids | 1 | 1999 | 447 | 0.030 |
Why?
|
| Anabolic Agents | 1 | 2019 | 256 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 17089 | 0.030 |
Why?
|
| CHO Cells | 1 | 2019 | 1376 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3796 | 0.030 |
Why?
|
| Transgenes | 1 | 1999 | 1014 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 8928 | 0.030 |
Why?
|
| Vaccination | 3 | 2018 | 3435 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3246 | 0.030 |
Why?
|
| DNA | 4 | 2023 | 7210 | 0.030 |
Why?
|
| Bone Density | 1 | 2008 | 3491 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 811 | 0.030 |
Why?
|
| Antibodies, Viral | 3 | 2018 | 3213 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Kinetics | 3 | 2019 | 6288 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1997 | 268 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2020 | 1494 | 0.030 |
Why?
|
| Protein S | 1 | 1995 | 29 | 0.030 |
Why?
|
| Cardiolipins | 1 | 2015 | 82 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 1737 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1995 | 1550 | 0.030 |
Why?
|
| Vitamin D | 1 | 2008 | 3270 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1995 | 287 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 796 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 3440 | 0.030 |
Why?
|
| Receptors, Neuropeptide | 1 | 1995 | 106 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2014 | 92 | 0.030 |
Why?
|
| Rhodamine 123 | 2 | 1993 | 37 | 0.030 |
Why?
|
| Microcirculation | 1 | 1999 | 1282 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2018 | 1472 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 2014 | 175 | 0.030 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2014 | 64 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1887 | 0.030 |
Why?
|
| Rhodamines | 2 | 1993 | 179 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 236 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1997 | 833 | 0.030 |
Why?
|
| Cell Division | 4 | 1995 | 4473 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2014 | 157 | 0.030 |
Why?
|
| COS Cells | 3 | 2002 | 1135 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2021 | 3948 | 0.030 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 2001 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 1947 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39312 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 2013 | 182 | 0.030 |
Why?
|
| PC12 Cells | 4 | 1993 | 317 | 0.030 |
Why?
|
| Zinc | 1 | 2017 | 675 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2448 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 1999 | 1492 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3317 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1999 | 2085 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 1065 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2019 | 2341 | 0.020 |
Why?
|
| International Cooperation | 1 | 2018 | 1434 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 260 | 0.020 |
Why?
|
| Motor Neurons | 1 | 1997 | 869 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 74889 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2013 | 2677 | 0.020 |
Why?
|
| Influenza Vaccines | 2 | 2014 | 780 | 0.020 |
Why?
|
| Adipocytes, Brown | 1 | 2012 | 160 | 0.020 |
Why?
|
| Alkaloids | 1 | 1992 | 192 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1995 | 490 | 0.020 |
Why?
|
| Macrophages | 2 | 2021 | 5784 | 0.020 |
Why?
|
| Heart-Assist Devices | 2 | 2014 | 1287 | 0.020 |
Why?
|
| United States Environmental Protection Agency | 1 | 1991 | 139 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 1991 | 123 | 0.020 |
Why?
|
| Government Agencies | 1 | 1991 | 161 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41706 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4349 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 210 | 0.020 |
Why?
|
| Synapses | 2 | 1997 | 1759 | 0.020 |
Why?
|
| Carbazoles | 1 | 1992 | 230 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1505 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 685 | 0.020 |
Why?
|
| Influenza, Human | 2 | 2018 | 1543 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2013 | 379 | 0.020 |
Why?
|
| Protective Agents | 1 | 2011 | 150 | 0.020 |
Why?
|
| Binding Sites | 4 | 2002 | 6013 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1944 | 0.020 |
Why?
|
| Growth Substances | 1 | 1992 | 759 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2012 | 898 | 0.020 |
Why?
|
| Base Sequence | 5 | 1995 | 12415 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Collagen | 1 | 1997 | 2635 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2009 | 121 | 0.020 |
Why?
|
| Synthetic Biology | 1 | 2011 | 188 | 0.020 |
Why?
|
| Life Style | 1 | 2020 | 3926 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 2671 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2009 | 65 | 0.020 |
Why?
|
| Seasons | 1 | 2014 | 1519 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 6306 | 0.020 |
Why?
|
| Actomyosin | 1 | 2009 | 115 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3582 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2002 | 3053 | 0.020 |
Why?
|
| Environmental Health | 1 | 1991 | 297 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 1836 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 1305 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 1103 | 0.020 |
Why?
|
| Capillaries | 2 | 2002 | 755 | 0.020 |
Why?
|
| Dystroglycans | 2 | 1998 | 62 | 0.020 |
Why?
|
| Receptor, trkC | 2 | 1999 | 63 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1995 | 1657 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1978 | 2160 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2007 | 68 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2007 | 36 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2007 | 125 | 0.020 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2007 | 72 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2011 | 1206 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2007 | 130 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1986 | 3788 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3831 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2188 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2013 | 5143 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2014 | 1281 | 0.020 |
Why?
|
| Adolescent | 2 | 2008 | 88902 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2009 | 591 | 0.020 |
Why?
|
| Integrins | 2 | 2002 | 839 | 0.020 |
Why?
|
| Phosphotyrosine | 2 | 1999 | 458 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15835 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 1057 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2006 | 165 | 0.020 |
Why?
|
| Skin | 1 | 1999 | 4499 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1990 | 1266 | 0.010 |
Why?
|
| Young Adult | 2 | 2022 | 59939 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1756 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 1986 | 391 | 0.010 |
Why?
|
| Salicylates | 1 | 2004 | 127 | 0.010 |
Why?
|
| Receptor, trkA | 2 | 1996 | 159 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 2551 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 1990 | 1467 | 0.010 |
Why?
|
| Child | 3 | 2008 | 80670 | 0.010 |
Why?
|
| Haploidy | 2 | 1981 | 128 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 661 | 0.010 |
Why?
|
| Brain Chemistry | 2 | 2000 | 951 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 250 | 0.010 |
Why?
|
| Lysine | 1 | 2007 | 998 | 0.010 |
Why?
|
| Fasting | 1 | 2009 | 1609 | 0.010 |
Why?
|
| Mutagenesis | 2 | 1999 | 1228 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 513 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3226 | 0.010 |
Why?
|
| Weight Loss | 1 | 2014 | 2712 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 2011 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 4410 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1986 | 1617 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 2 | 1998 | 1326 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2002 | 348 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 1674 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 1927 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5795 | 0.010 |
Why?
|
| Actins | 1 | 2009 | 2061 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2062 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10101 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1990 | 2571 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4652 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1990 | 10263 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2012 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2002 | 973 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 1750 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1997 | 6105 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1995 | 2746 | 0.010 |
Why?
|
| Biological Transport | 2 | 1995 | 2083 | 0.010 |
Why?
|
| Torpedo | 1 | 1999 | 170 | 0.010 |
Why?
|
| Prothrombin | 1 | 2000 | 194 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 36570 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1999 | 294 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 778 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1999 | 439 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1986 | 2201 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 573 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 751 | 0.010 |
Why?
|
| Quail | 1 | 1997 | 40 | 0.010 |
Why?
|
| Solubility | 1 | 1999 | 1078 | 0.010 |
Why?
|
| Properdin | 1 | 1976 | 16 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1997 | 77 | 0.010 |
Why?
|
| Monocytes | 1 | 2006 | 2599 | 0.010 |
Why?
|
| Paralysis | 1 | 1998 | 250 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1999 | 1767 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 13050 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 3093 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1996 | 224 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 5502 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 1995 | 48 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 3789 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1976 | 479 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 5038 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1997 | 358 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 54872 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1995 | 195 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 725 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1995 | 524 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 1751 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1997 | 901 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1998 | 1208 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1995 | 390 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1995 | 294 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1989 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 3642 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1997 | 1757 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 663 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3803 | 0.010 |
Why?
|
| Indole Alkaloids | 1 | 1992 | 23 | 0.010 |
Why?
|
| United States | 2 | 1991 | 72945 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2177 | 0.010 |
Why?
|
| Heterozygote | 1 | 1999 | 2795 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 27158 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1995 | 529 | 0.010 |
Why?
|
| Prefrontal Cortex | 1 | 2002 | 2224 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 4914 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1750 | 0.010 |
Why?
|
| Staurosporine | 1 | 1992 | 241 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1030 | 0.010 |
Why?
|
| Protein Engineering | 1 | 1995 | 554 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 2826 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1986 | 6613 | 0.010 |
Why?
|
| Models, Neurological | 1 | 1998 | 1747 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1991 | 1141 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7438 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 1892 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1991 | 327 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1993 | 2478 | 0.000 |
Why?
|
| Cross-Linking Reagents | 1 | 1991 | 689 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1431 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1993 | 1592 | 0.000 |
Why?
|
| Hippocampus | 1 | 2000 | 3776 | 0.000 |
Why?
|
| Astrocytes | 1 | 1995 | 1351 | 0.000 |
Why?
|
| Phytohemagglutinins | 1 | 1986 | 164 | 0.000 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 1986 | 8 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1986 | 174 | 0.000 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3886 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 548 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1991 | 732 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13642 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1990 | 1968 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1995 | 5388 | 0.000 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1986 | 565 | 0.000 |
Why?
|
| Karyotyping | 1 | 1986 | 1176 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1986 | 2168 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1990 | 1367 | 0.000 |
Why?
|
| Chromosomes | 1 | 1986 | 578 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1986 | 1417 | 0.000 |
Why?
|
| Rheumatoid Factor | 1 | 1978 | 185 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1978 | 384 | 0.000 |
Why?
|
| Homozygote | 1 | 1981 | 1775 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1978 | 1392 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1976 | 1524 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1976 | 2342 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1990 | 26387 | 0.000 |
Why?
|
| Alleles | 1 | 1981 | 6896 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1978 | 2115 | 0.000 |
Why?
|
| Pedigree | 1 | 1976 | 4539 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1976 | 4618 | 0.000 |
Why?
|
| Infant | 1 | 1990 | 36459 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1990 | 42577 | 0.000 |
Why?
|
| Recurrence | 1 | 1978 | 8507 | 0.000 |
Why?
|